Skip to main content

Table 3 Summary of Lipid peroxides and nitric oxide analysis in RIN5F cells treated with Alloxan (Pre-treatment) /STZ(Simultaneous) and suboptimal doses of AA (10 μg/ml) + BDNF (50 ng/ml)

From: PUFAs, BDNF and lipoxin A4 inhibit chemical-induced cytotoxicity of RIN5F cells in vitro and streptozotocin-induced type 2 diabetes mellitus in vivo

SUMMARY OF THE ANALYSIS OF LIPID PEROXIDES AND NITRIC OXIDE LEVELS IN RIN5F CELLS TREATED WITH AL/STZ

CHEMICAL

GROUP

LIPID PEROXIDES (μM TMOP)

NITRIC OXIDE (μM Nitrite)

Supernatant Lysates

Supernatant Lysates

ALLOXAN

CONTROL

0.47 ± 0.04

1.2 ± 0.04

0.58 ± 0.03

1.2 ± 0.03

AL(6 mM)

0.8 ± 0.04*

1.6 ± 0.09*

0.87 ± 0.05

1.4 ± 0.05*

AA(10 μg/ml)

0.45 ± 0.06

1.1 ± 0.02

0.54 ± 0.06

1.15 ± 0.03

BDNF(50 ng/ml)

0.44 ± 0.03

1.3 ± 0.05

0.43 ± 0.03

1.18 ± 0.07

AA + BDNF

0.37 ± 0.03

1.3 ± 0.1

0.49 ± 0.04

1.16 ± 0.05

AL + AA(10 μg/ml)

1.2 ± 0.03#

1.3 ± 0.05#

1.42 ± 0.03 #

1.16 ± 0.05 #

AL + BDNF

0.9 ± 0.03§

0.9 ± 0.05§

0.94 ± 0.03§

1.25 ± 0.02§

AL + AA + BDNF

0.74 ± 0.06

1.4 ± 0.05

0.89 ± 0.07

1.12 ± 0.05

STREPTOZOTOCIN

CONTROL

0.68 ± 0.05

1.3 ± 0.04

0.64 ± 0.04

1.08 ± 0.05

STZ(20 mM)

0.89 ± 0.03

1.6 ± 0.09

0.83 ± 0.04

1.52 ± 0.06

AA(10 μg/ml)

0.55 ± 0.03

1.2 ± 0.02

0.61 ± 0.05

1.11 ± 0.02

BDNF(50 ng/ml)

0.54 ± 0.01

1.2 ± 0.03

0.57 ± 0.02

1.09 ± 0.02

AA + BDNF

0.51 ± 0.03

1.2 ± 0.03

0.58 ± 0.01

1.11 ± 0.05

STZ + AA(10 μg/ml)

0.72 ± 0.06#

0.9 ± 0.09#

0.79 ± 0.07#

1.09 ± 0.04#

STZ + BDNF

0.66 ± 0.08§

0.8 ± 0.09§

0.69 ± 0.4§

0.9 ± 0.08§

STZ + AA + BDNF

0.59 ± 0.03

1.3 ± 0.03

0.65 ± 0.0

1.15 ± 0.05

  1. Lipid peroxides formed are expressed as μmoles of TMOP formed; Nitric oxide formed is expressed as μ moles of nitrite formed. *P < 0.001 Vs Untreated control and § P ≤ 0.05, # P ≤ 0.02, * P < 0.01, ** P < 0.001 Vs AL/STZ -treated group